0001209191-21-006709.txt : 20210202
0001209191-21-006709.hdr.sgml : 20210202
20210202155541
ACCESSION NUMBER: 0001209191-21-006709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210131
FILED AS OF DATE: 20210202
DATE AS OF CHANGE: 20210202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Jason Drew
CENTRAL INDEX KEY: 0001821479
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 21581272
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 400 ALEXANDER PARK DRIVE
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-31
0
0001668243
UroGen Pharma Ltd.
URGN
0001821479
Smith Jason Drew
C/O UROGEN PHARMA LTD.
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
0
1
0
0
General Counsel
Stock Option (right to buy)
22.07
2021-01-31
4
A
0
8000
0.00
A
2031-01-30
Ordinary Shares
8000
8000
D
Restricted Stock Units
2021-01-31
4
A
0
2500
0.00
A
Ordinary Shares
2500
2500
D
1/3 of the shares underlying the stock option will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2022, January 31, 2023 and January 31, 2024.
/s/ Jason D. Smith
2021-02-02